The nationwide experiment will initially include around 100,000 volunteers.
From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.
The Scientist
Most Recent
Fotis Kafatos, a Greek researcher famous for his work on malaria, has died at age 77.
Academics Criticize University of Rochester’s Handling of Sexual Harassment Case
| November 15, 2017
An open letter from hundreds of faculty members in the U.S. and abroad declares they won’t encourage students to pursue education or careers there.
A team has engineered two stem cell lines into “synthetic T cells” that destroy breast cancer cells in vitro.
Investigations into cases of wrongdoing by professors are increasingly in the public eye. But are colleges and universities doing enough to deal with the problem?
An overview of this year's results in graphical form
Take a break from the bench to puzzle and peruse.
While wiping fear from our brains may seem attractive, the emotion is an essential part of our behavioral repertoire.
Industry professionals make more than academic researchers, but for professors, it may not be about the money.
The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas.
Popular Now
-
The Nutshell Estonia Offers Free Genetic Testing to Residents -
Daily News Human Brain Organoids Thrive in Mouse Brains After implantation, the tissue developed blood vessels and became integrated into neuronal networks in the animals’ brains.
-
The Nutshell New Ovarian Cancer Vaccine Shows Promise A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.
-
Daily News The Second March for Science a Smaller Affair Many cities around the globe, including Washington, DC, saw shrunken crowd sizes, and numerous events turned into rallies rather than processions.
Current Issue
© 1986-2018 The Scientist
